Our resident genetic genius Samantha Malka found a gene 🧬 causing #RetinitisPigmentosa in 17 individuals of Afro-Caribbean descent in a previous unknown location!
That’s as much as I know & it’s fabulous!!! 🤗😬💐
Go talk to her to find out more B0121 #ARVO2024 NIHR Moorfields BRC
Interesting results presented by our PhD student helena isla in #ARVO2024 . Stop by if you have the change! #retina #retinitispigmentosa #organoids .
Discover personalized treatment options 4 Stargardt’s Disease & Retinitis Pigmentosa! Your path to clearer vision starts here. Book your appointment today: [email protected] #electroacupuncture #stargardtsdisease #retinitispigmentosa #firatliclinic #clearervision #visionhope
Hope Neuro & Cardiac Multispeciality Hospital Sangareddy
Retinitis Pigmentosa
Dr. Vinay Jitta
Ophthalmologist
For Appointment
8885333053
#retinitispigmentosa #Eyesproblem #pigmentos #EyeDiseasePrevention
SRO crowd at #ARVO2024 for Dr. Allen Ho's presentation featuring results from @NStherapeutics Phase 2b/3 #clinicaltrial of our MCO-010 #optogenetic #genetherapy for #retinitispigmentosa . ARVO #ophthalmology
Faulty Photocopies: Rhodopsin #gene duplication newly-identified genetic fault underlying cases of #vision -degenerating disease #retinitispigmentosa and modelling in an #organoid . Image & research by Sangeetha Kandoi et al University of California in eLife - the journal. On bpod.org.uk/archive/2024/5…
Nanoscope Therapeutics MCO-010 #genetherapy is featured in 6 presentations at #ARVO24 beginning Mon. 5/6 when Dr. Allen C. Ho presents 12-month results from our RESTORE trial for #retinitispigmentosa . Hope to see you there and connect at our booth #4620. #ophthalmology Ophthalmology Innovation Source
Join us May 14 at 9 AM in Rayburn Building Rm. 2075! We're hosting a Congressional Briefing and Breakfast on Rare Eye Diseases. Patient advocates will share heartfelt stories, while experts from U-M Kellogg Eye Center & Alkeus Pharma will focus on #Stargardtdisease & #retinitispigmentosa
A Patient with Albinism and #RetinitisPigmentosa , a Case Report AJO Case Reports | #ECM sciencedirect.com/science/articl…
Two-year data from a phase 1/2 trial of eyeDNA Therapeutics' #genetherapy for #retinitispigmentosa sets up pivotal trials, says the newly formed subsidiary of French #biotech Coave. #ARVO24
pharmaphorum.com/news/eyedna-pl…